Predictors of Treatment Outcomes among Multidrug Resistant Tuberculosis Patients in Tanzania

Table 7

Adjusted OR after multivariate analysis for predictors of treatment outcome of mortality/death (N=332).

Characteristics	Died	Other treatment categories	aOR(95% CI)	p-value
	N (%)	N (%)
Cavitary lesions on CXR (N=279)
(i) Yes	8(12.5)	56(87.5)	0.55(0.34-0.91)	0.019
(ii) No	29(13.7)	182(86.3)
Smoking (N=177)
(i) Yes	24(31.6)	52(68.4)	2.31(1.35-5.01)	0.043
(ii) No	14(12.8)	95(87.2)
Baseline positive sputum smear (N=268)
(i) Yes	33(16.0)	173(84.0)	1.24(0.48-3.21)	0.661
(ii) No	13(14.9)	74(85.1)
Baseline positive sputum culture (N=253)
(i) Yes	16(10.5)	136(89.5)	0.55(0.23-1.34)	0.190
(ii) No	17(17.3)	81(82.7)
HIV status
(i) Yes	22(19.5)	91(80.5)	1.10(0.49-2.50)	0.815
(ii) No	34(15.9)	180(84.1)
Diabetes (N=319)
(i) Yes	1(20.0)	4(80.0)	1.49(0.33-6.71)	0.609
(ii) No	52(16.8)	258(83.2)
Isoniazid
(i) Resistant	17(13.3)	111(86.7)	0.77(0.24-2.46)	0.661
(ii) susceptible	1(9.1)	10(90.9)
Rifampicin
(i) Resistant	33(16.7)	165(83.3)	1.27(0.50-3.22)	0.614
(ii) Susceptible	0(0.0)	5(100.0)
Streptomycin
(i) Resistant	12(14.8)	67(85.2)	0.54(0.10-2.78)	0.459
(ii) Susceptible	1(3.0)	32(97.0)
Ethambutol
(i) Resistant	11(15.3)	61(84.7)	0.97(0.20-4.68)	0.974
(ii) Susceptible	2(5.6)	34(94.4)